動画検索
関連広告
検索結果
Introduction to Rohan Hockings and PYC Therapeutics
PYC focuses on diseases caused by a mutation in one gene
Significant market opportunities in PKD and ADOA
Expected timeline and milestones for drug candidates
Managing challenges in clinical development and regulatory pathways
Pursuing partnerships and collaborations for enhanced therapies
Expanding into new therapeutic areas and leveraging RDNA targeted platform
Conclusion and well wishes for PYC's venture